LONDON, April 24, 2017 /PRNewswire/ -- This expansion is attributed to the increasing cases of trauma and rising number of hospital and trauma care centers facilitating emergency treatments. This creates a need to procure blood to suffice the demand, thus, boosting the market for immunohematology tests and products.
A deeper analysis on the report at https://www.reportbuyer.com/product/4523071/
In April 2016, The Indian Red Cross Society launched an application (app) to facilitate blood banking facility. The app is expected to address the shortage issue in the region. Moreover, in 2011, the first type of this application was launched by Hemo bioscience, Inc., a U.S.-based company. The company made the app available for free for apple users.
Further Key Findings from the Study Suggest:
· In December 2013, Sysmex Corporation received the German Design Award for its XN-2000 hematology reagent. Almost 1,900 products were nominated for the award.
· In 2015, North America dominated the market with a revenue share of more than 40%. In the U.S., there is a patient requiring transfusion every 2 seconds. The daily consumption of blood is approximately 36,000 units per day. This indicates the huge opportunity of growth in this region.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-immunohematology-market-forecast-to-value-usd-23-billion-by-2024-300444490.html